Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Hematology|February 20, 2009
Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myelomaHirokazu Miki, Shuji Ozaki, Osamu Tanaka, et al.
Plos One|April 3, 2010
Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growthKyoko Takeuchi, Masahiro Abe, Masahiro Hiasa, et al.
International Journal of Hematology|April 6, 2024
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acidYusuke Inoue, Asuka Oda, Yusaku Maeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]Shingen Nakamura, Shigeaki Kimura, Masahiro Kashima, et al.
International Journal of Hematology|May 28, 2013
Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomibShingen Nakamura, Hirokazu Miki, Shinsuke Kido, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 12, 2018
Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndromeShingen Nakamura, Momoyo Azuma, Tomoko Maruhashi, et al.
BMJ Supportive & Palliative Care|April 3, 2024
Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective studyMamiko Takahashi, Shin Kondo, Kumiko Kagawa, et al.
Pageof 9